David Drutz - 15 Jun 2022 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Director
Signature
/s/Richard Eisenstadt, as Attorney-in-Fact
Issuer symbol
ALT
Transactions as of
15 Jun 2022
Net transactions value
+$8,000
Form type
4
Filing time
16 Jun 2022, 21:27:23 UTC
Previous filing
25 May 2022
Next filing
30 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Purchase $8,000 +1,000 +5.3% $8.00 20,012 15 Jun 2022 Direct
holding ALT Common Stock, par value $0.0001 333 15 Jun 2022 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President.